1. Circulating Tumor DNA is Effective for Detection of KRAS Mutation in Colorectal Cancer: A Meta-Analysis
   Min Tang et al, 2017, The International Journal of Biological Markers CrossRef
2. Rapid label-free visual detection of KRAS mutations using peptide nucleic acid and unmodified gold nanoparticles
   Xihong Zhao et al, 2017, RSC Adv. CrossRef
3. Peptide Nucleic Acid-Based Biosensors for Cancer Diagnosis
   Roberta D’Agata et al, 2017, Molecules CrossRef
4. Colorectal cancer: using blood samples and tumor tissue to detectK-rasmutations
   Yang Li et al, 2015, Expert Review of Anticancer Therapy CrossRef
5. The diagnostic accuracy of circulating free DNA for the detection of KRAS mutation status in colorectal cancer: A meta‐analysis
   Wenli Xie et al, 2019, Cancer Medicine CrossRef
6. Detection of KRAS mutations of colorectal cancer with peptide-nucleic-acid-mediated real-time PCR clamping
   Xihong Zhao et al, 2016, Biotechnology & Biotechnological Equipment CrossRef
7. Versatility of peptide nucleic acids (PNAs): role in chemical biology, drug discovery, and origins of life
   Chiranjeev Sharma et al, 2017, Chemical Biology & Drug Design CrossRef
8. KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer
   Jian-Ming Xu et al, 2014, Journal of Experimental & Clinical Cancer Research CrossRef
9. Diagnostic RAS mutation analysis by polymerase chain reaction (PCR)
   Ian A. Cree, 2016, Biomolecular Detection and Quantification CrossRef
10. PNA clamping-assisted fluorescence melting curve analysis for detecting EGFR and KRAS mutations in the circulating tumor DNA of patients with advanced non-small cell lung cancer
    Ji-Youn Han et al, 2016, BMC Cancer CrossRef